There have been commendable breakthroughs in the cannabis industry in the recent past, particularly in the field of medical marijuana thanks to the ever evolving technology and marijuana laws.   The legalization of marijuana either for medical or adult recreational use in more than thirty states in the U.S. has over time prompted tremendous changes and discoveries in the medical cannabis industry.  Consequently, professional research on the medical benefits of marijuana has gone a notch higher.

Latest research on medical marijuana

Currently, the Multidisciplinary Association for Psychedelic Studies in collaboration with the Colorado Department of Public Health and Environment is undertaking a clinical trial that seeks to establish if marijuana could be used to treat post-traumatic stress disorder in veterans. Specifically, the study is designed to evaluate the medicinal benefits of marijuana among veterans suffering from PTSD. The results of the clinical trial would help to shed light on the efficacy and safety of medical marijuana in managing symptoms of PTSD.

GW Pharmaceuticals, a British company has established that medical marijuana can be used to treat brain cancer. In a press release, the company which has heavily invested in oncologic research recently provided clinical evidence which indicates that cannabinoids are effective in treating various forms of cancer and suppression of tumor growth. Furthermore, oncologic research conducted by experts from the University of London has revealed that using CBD and THC alongside chemotherapy   is more effective compared to administering chemotherapy exclusively. These research findings would be helpful in minimizing chemotherapy which comes with harsh side effects.

Medical research experts at the University of Manitoba, Canada have demonstrated the potency of marijuana as a pain reliever in multiple sclerosis patients. So far, researchers have performed a series of tests on mice and have conclusively established that CBD oil could be used to manage neuropathic pain associated with multiple sclerosis. Although tests have not been applied on humans, there is a likelihood of developing CBD oil for human use, should the results continue to be positive.   

Cannabis Science Inc. a biotech company based in California is currently developing a transdermal patch that would be used to treat fibromyalgia and other nerve pain disorders. The transdermal patch contains two active cannabinoids -CBD and THC. This cannabis based medicine is designed to deliver a steady supply of therapeutic marijuana through the skin into the bloodstream.